Stock Market News for May 22, 2026
283 news published.
Market movers & earnings
Booz Allen Hamilton (BAH) posted fourth-quarter and full-year fiscal 2026 results, with backlog and consulting margins investors will watch for cues on government spending and margin durability.
BJ's Wholesale Club Holdings (BJ) released first-quarter fiscal 2026 results, where same‑store sales and membership trends continue to signal consumer resilience in value retail.
Biotech & ASCO: approvals, trial reads and payer signals
AstraZeneca (AZN) won U.S. approval of DATROWAY® (datopotamab deruxtecan), the first TROP2‑directed ADC cleared for first‑line metastatic triple‑negative breast cancer—an outcome that could shift oncology treatment patterns and revenue mix.
Gilead (GILD) received FDA accelerated approval for Hepcludex®, the first approved therapy for chronic hepatitis D and a new commercial lane for its infectious‑disease portfolio.
Agios (AGIO) and partners secured EU approval for PYRUKYND® (mitapivat) in adults with thalassaemia, supporting partner economics in rare‑disease markets.
AbbVie (ABBV) received a positive CHMP opinion for MAVIRET® in acute hepatitis C, a regulatory tailwind for its antiviral franchise.
AI, cloud and enterprise tech
Micron (MU) advanced a manufacturing expansion in Virginia, reinforcing on‑shore memory capacity amid rising demand for AI and cloud infrastructure.
Align Technology (ALGN) plans a new multi‑million dollar facility in Hyderabad, India, a move that could ease supply constraints and lower unit costs over time.
China & Asia: consumer, fintech and regulatory developments
Futu Holdings (FUTU) expanded crypto features via Moomoo's Texas crypto rollout while disclosing an investigation notice from the CSRC, a regulatory overhang that could weigh on cross‑border brokerage flows.
Yum China (YUMC) said KFC's KPRO surpassed 300 locations, reinforcing franchising momentum that may support same‑store sales recovery narratives.
Corporate moves, compliance and capital
Listing and filing notices continue to pile up among small caps. SemiLux International (SELX) received a Nasdaq staff determination letter and plans to request a hearing, keeping its listing status uncertain.
XTLB (XTLB) got a staff delist determination, a near‑term existential risk for shareholders.
SCYNEXIS (SCYX) announced a one‑for‑eight reverse stock split, a common step to meet listing thresholds and stabilize capital structure.
Several companies disclosed late filings or notices today. Notable items include Atlantic American Corporation (AAME) receiving a Nasdaq notice about a delayed Form 10‑Q, La Rosa Holdings (LRHC) getting a notification of deficiency, and Nuvve (NVVE) announcing a Nasdaq notice on a late 10‑Q.
Other compliance alerts to monitor: Laser Photonics (LASE) received a Nasdaq notice for a delayed quarterly report, Global Interactive Technologies (GITS) disclosed a delinquency compliance alert, and KNOREX (KNRX) reported a NYSE American notice on a delayed annual report.
Calidi Biotherapeutics (CLDI) filed a required NYSE American disclosure, a procedural step investors should note for governance and liquidity context.
Financing, M&A and payments
Mission Produce / Calavo Growers (AVO) cleared a key hurdle as their merger obtained Mexican antitrust approval, removing a regulatory obstacle and increasing the odds of a deal close.
Automotive & mobility updates
Faraday Future (FFAI) said shareholders approved proposals at its annual meeting intended to enhance financial stability and accelerate its EAI robotics strategy—steps aimed at de‑risking execution for investors.
Real estate & consumer
LGI Homes (LGIH) unveiled Allen Townhomes north of Seattle, a product launch that highlights inventory and margin strategies in for‑sale housing markets.
Smaller moves and corporate hires
- Momentus (MNTS) granted inducement awards to six new employees, a hiring incentive aimed at shoring up engineering and operations.
Smaller-cap updates worth watching
Keep tracking retailers and healthcare developers for fresh earnings and regulatory signals; small‑cap filing notices remain a common source of volatility this session.
Stay ahead of the market with our list of today's most important stock news and financial updates. Whether you're a day trader, long-term investor, or market enthusiast, our news feed covers everything you need to know about publicly traded companies.
Our news feed is designed for investors who want to stay informed about the latest developments affecting their portfolio or watchlist. Whether you're researching potential investments, monitoring your current holdings, or simply staying up-to-date with market trends, our stock news page provides the information you need to make informed decisions.
What You'll Find on This Page:
- Breaking financial news and market-moving headlines
- FDA approvals and clinical trial results for biotech and pharma stocks
- Stock offerings, dividends, and other corporate actions
- Mergers, acquisitions, and strategic partnerships
- Business news affecting company performance and stock prices
- Easy-to-use tags for quick news categorization
- Stock tickers for instant company identification
- AI sentiment analysis to gauge market reaction
- Estimated impact scores to assess potential stock movement